By Lucy Parkinson, VP of Investor Research, LSN
Many of us in the biotech world are already planning out our time at the annual San Francisco conference week in January, and early stage investors are no exception. Many have already put their names down for RESI San Francisco – which is no surprise, as over 500 investors registered for this event in 2018! See below for some of the investors who will be coming to the 2019 event.
LSN held our first RESI San Francisco event in 2015. Previously, LSN staff had attended San Francisco’s annual healthcare week and noticed that the events there all focused on later-stage companies and the public biotech markets; there was no real, focused venue for early stage startups and early stage investors to meet. We therefore brought RESI to San Francisco, and have often heard from players in the early stage world that it’s filled a real need amid the hectic conference week. We hope you can join us there on January 8th, 2019.
CONFIRMED INVESTORS AND STRATEGIC PARTNERS
As of October 25th, 2018
And More…
Leave a Reply